Henry Rath is the Vice President of Business Development at Seres. He has over 20 years of experience in the biotechnology industry with roles spanning corporate finance, strategy, and business development. Prior to joining Seres, he worked at Amgen Inc., Catabasis Pharmaceuticals Inc., and Baxter Biopharmaceuticals Inc., and completed licensing and mergers and acquisitions transactions in the United States as well as internationally. Mr. Rath began his career with roles in the banking and consulting industries focusing on biotechnology with Oppenheimer & Co. Inc. and LEK Consulting. Mr. Rath earned his undergraduate degree from Harvard College and his M.B.A. from the Wharton School of the University of Pennsylvania.